Why the study?
Women are more frequently diagnosed with MINOCA, but the influence of sex on long-term outcomes remains unclear.
Does male sex predict worse long-term outcomes compared to female sex in patients with MINOCA?
Does male sex predict worse long-term outcomes compared to female sex in patients with MINOCA?
In patients with MINOCA, male sex is associated with higher 3-year rates of adverse events, including mortality and myocardial infarction, despite being younger and having less diabetes at baseline.
Answers are grounded in this paper and cite their sources.
Males with MINOCA may face higher long-term MI and mortality risk; leaves open need for sex-specific management trials.
Myocardial infarction with nonobstructive coronary arteries (MINOCA) constitutes 3-15% of all acute myocardial infarctions. Women are more frequently diagnosed with MINOCA, although the influence of sex on long-term outcomes is still unclear. In this study we aimed to compare sex-based differences in baseline characteristics and clinical outcomes in patients with suspected MINOCA. We have retrospectively analyzed 6063 patients diagnosed with MINOCA (3220 females and 2843 male patients) from combined 3 large polish registries (PL-ACS, SILCARD and AMI-PL). Male patients were significantly younger (63 (55-74) vs. 71 (61-79) years, p < 0.05) and less frequently diabetic (20.1% vs. 24.1%, p < 0.05). Mortality was significantly higher in male population (11.8% vs. 10.2%, p < 0.05 at 1 year and 17.6% vs. 15.0%, p < 0.05 at 3 years). Male sex was an independent predictor of both mortality (HR = 1.29; CI 1.11-1.51; p < 0.05) and myocardial infarction (HR = 1.39; CI 1.1-1.75, p < 0.05) at 3 years follow-up. All-cause readmission rates were similar in male and female patients both at 1 year (46.0% vs. 44.4, p = 0.2) and 3 years follow-up (56.4% vs. 56.5%, p = 0.93). However, cardiovascular readmissions were more prevalent in male patients at both timepoints (33.9% vs. 29.10%, p < 0.05 at 1 year, and 41.0% vs. 37.6%, p < 0.05 at 3 years). This large-scale registry-based analysis demonstrated higher 3 years rates of adverse events, including death and MI among male patients with suspected MINOCA.
No takes yet. Share an insight, caveat, or question.
Milewski et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: